News

PharmaCorp Rx Inc. Secures C$23 Million in Public Offering

PharmaCorp Rx Inc. Secures C$23 Million in Public Offering

PharmaCorp Rx Inc. Secures C$23 Million in Public Offering

CALGARY, Alberta – PharmaCorp Rx Inc. (“PharmaCorp” or the “Company”) (TSXV: PCRX) has successfully completed its previously announced bought deal public offering, demonstrating a solid engagement with investors. This financing initiative was co-led by Canaccord Genuity Corp. and Acumen Capital Finance Partners Limited, along with notable participation from Raymond James Ltd., iA Private Wealth Inc., and Bloom Burton Securities Inc. The offering allowed the Underwriters to purchase 54,855,000 units at a price of C$0.42 per unit, yielding the Company roughly C$23.0 million in total gross proceeds, including the complete exercise of the over-allotment option.

Details of the Offering

Each unit offered in this transaction comprises one common share in the Company and one-half of a common share purchase warrant. Specifically, each whole warrant is designed to enable the holder to acquire one common share at an exercise price of C$0.50 until November 12, 2027. The Company has already applied for and received conditional approval to list these warrants on the TSX Venture Exchange (“TSXV”) under the ticker symbol “PCRX.WT.” Final acceptance from the TSXV is pending, contingent upon the Company meeting all necessary listing requirements.

Utilization of Proceeds

The net proceeds garnered from this offering are earmarked for future acquisition opportunities and fulfilling general working capital needs. It's crucial for PharmaCorp to secure financing to sustain and enhance its operations amidst the ever-evolving pharmacy landscape.

Participation of Directors and Officers

In an additional show of confidence, directors and officers of PharmaCorp participated in the offering, acquiring a total of 3,762,010 units. This involvement is classified under “related party transactions” in accordance with TSX Venture Exchange policy. However, PharmaCorp has determined that exceptions to the related party policies apply, ensuring compliance without compromising governance standards. Overall, the offering resulted in no new insiders or changes in control of the Company.

Compensation to Underwriters

As a token of gratitude for the Underwriters’ services, the Company compensated them with a cash fee equivalent to 6.0% of the gross proceeds, excluding certain sales. This resulted in an aggregate commission of $1,134,633. Furthermore, the Company granted an additional 2,026,130 broker warrants to the Underwriters, each warrant being exercisable until November 12, 2026, at an exercise price of C$0.42 per unit.

About PharmaCorp Rx Inc.

PharmaCorp is pioneering a fresh approach within the Canadian pharmacy arena by focusing on pharmacy acquisitions and operational ownership. The Company strives to empower pharmacists by converting them into equity partners, thus ensuring a seamless succession plan for those looking to retire from the pharmacy business. With a robust combination of capital, strategic insight, and operational excellence, PharmaCorp is diligently creating a national community pharmacy network under the PharmaChoice Canada banner. Currently, the Company operates seven pharmacies bearing the PharmaChoice Canada name and is actively pursuing acquisitions to expand both bannered and independent pharmacies across Canada, aligning with its strategic partnership with PharmaChoice Canada.

Collaboration with Pharmacy Owners

PharmaCorp invites pharmacy owners contemplating succession or sale to explore potential collaboration opportunities. The Company is committed to facilitating smooth transitions that are beneficial for all parties involved and contribute positively to the local communities.

Get in Touch

For those interested in pursuing partnerships or needing further information about the acquisition process, they can visit PharmaCorp’s website or connect confidentially with the team. The Company's dedication to preserving legacies while serving community needs is at the core of its philosophy.

Contact Information

For additional inquiries, please reach out to:

Mr. Alan Simpson
Suite #203, 303 Wellman Lane, Saskatoon, SK S7T 0J1
Tel: (306) 536-3771

Frequently Asked Questions

What is the total amount raised in PharmaCorp's offering?

PharmaCorp raised a total of approximately C$23 million through its recent public offering.

What will the proceeds from the offering be used for?

The proceeds will be utilized for potential acquisitions and general working capital needs.

Who are the underwriters for this offering?

The offering was co-led by Canaccord Genuity Corp. and Acumen Capital Finance Partners Limited, along with Raymond James Ltd., iA Private Wealth Inc., and Bloom Burton Securities Inc.

How are the warrants structured in this offering?

Each unit consists of one common share and one-half of a warrant, with each whole warrant allowing the holder to purchase one additional common share at a price of C$0.50 until 2027.

How can pharmacy owners learn more about PharmaCorp's acquisition program?

Interested pharmacy owners can reach out directly to PharmaCorp or visit their website for more information on their acquisition program.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Modexus Opens a $500 Million Buyback With Real Caveats

Updated Category News Views 68

A half-billion-dollar buyback authorization can make a stock crowd sit up fast, and Modexus Solutions has plainly chosen that moment. On November 18, 2026, the Racine, Wisconsin-based thermal-management company said its board authorized repurchases of up to $500 million of common stock. For holders of NYSE:MOD, that is a meaningful declaration of intent. It says...

Continue Reading
Ampace Fire Test Gives Data Centers Useful Evidence

Updated Category News Views 109

Battery cabinets are becoming the awkward guest in the AI data-center boom: absolutely necessary, expensive to install, and nobody wants to discover their failure behavior during a real emergency. Ampace’s newly presented PU100 large-scale fire-test results deserve attention for that reason. This is not a magic safety stamp, and the company says the findings apply only...

Continue Reading
Google Search Data Sharing Faces a Privacy Reality Check

Updated Category News Views 77

Search queries are messy little confessions, and that is exactly why this case deserves more than a bureaucratic shrug. Woodway Assurance's independent assessment says Google's search-query data could be treated as anonymized for sharing under the Digital Markets Act, but only if the European Commission tightens parts of its July 2026 framework. That is not a clean bill...

Continue Reading
Markel Elevates War Risk Expertise in London Market

Updated Category News Views 73

A Specialty Desk Gets Its Own Weather Vane War and political violence underwriting is not a corner of insurance where a fancy title change can be shrugged off. The ground shifts under the policyholder, the broker and the carrier without much warning, and a bad call can sit on a book for years. Markel Insurance has named Chloe Gordge Director of War and Political Violence...

Continue Reading
Linkind's Best Buy Push Tests Smart Outdoor Demand

Updated Category News Views 77

Holiday lights have quietly become a year-round hardware category, and Linkind wants a louder seat at the table. The smart-lighting brand says three outdoor products have been in Best Buy stores across the United States since October 17, 2026: permanent exterior lights, decorative string lights, and solar pathway lights. That is a real distribution step, not some grand...

Continue Reading
BKV Energy's $400,000 Loyalty Bet Has a Real Point Behind It

Updated Category News Views 13

Retail power customers rarely send thank-you notes; they switch plans, complain about bills, or quietly vanish. That is why BKV Energy putting more than $400,000 into its third annual ElectroShare payout deserves a harder look than the usual feel-good loyalty announcement. A Retention Expense With Some Teeth The payout has climbed quickly: roughly $113,000 in the first...

Continue Reading
Cytonics Refines CYT-108 Trial Plan With Decade OA Data

Updated Category News Views 57

A Better Map Is Not a Working Drug Knee osteoarthritis has chewed up plenty of promising development plans because the disease moves at an aggravatingly uneven crawl. Cytonics has done something sensible before pushing deeper into CYT-108: it went back to long-term untreated patient data and asked which knees actually deteriorate fast enough for a trial to detect...

Continue Reading
Pacific Surfliner Faces Thanksgiving Capacity Test

Updated Category News Views 23

Thanksgiving traffic on Southern California freeways is its own yearly punishment, and the Pacific Surfliner is making a sensible pitch: leave the car parked and let the coast roll past the window. For travelers, that can be a real relief. For anyone watching public transportation, this is also a useful little stress test of whether a busy state-supported rail corridor...

Continue Reading
Unishippers Climbs 18 Slots on 32.4% Sales Growth Run

Updated Category News Views 147

Thirty new franchise units can move the needle fast Unishippers did not inch its way up the Franchise Times Top 400; it put up a number that deserves a hard look. Sales rose 32.4% in 2025, the company added 30 franchise units, and the result was an 18-place jump to No. 81 on the 2026 ranking. In the shipping category, it was named the sales-growth leader. For a business...

Continue Reading
LEPAS AURA Signals a Sharper Design Bet for Future Cars

Updated Category News Views 50

A porcelain-smooth concept car is not a balance sheet, but it can tell you where a young automotive brand intends to spend its attention. LEPAS unveiled AURA in October at its first Global Elegant Lifestyle Week, presenting it as the brand's first global concept car and a fresh expression of its Leopard Aesthetics design language. That matters because AURA is plainly not...

Continue Reading